Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial.

@article{Katritsis2017CatheterAV,
  title={Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial.},
  author={Demosthenes G. Katritsis and Theodoros A Zografos and George D. Katritsis and Eleftherios Giazitzoglou and Vasilios Vachliotis and George Paxinos and A. John Camm and Mark E. Josephson},
  journal={Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology},
  year={2017},
  volume={19 4},
  pages={602-606}
}
Aims To conduct a randomized trial in order to guide the optimum therapy of symptomatic atrioventricular nodal re-entrant tachycardia (AVNRT). Methods and Results Patients with at least one symptomatic episode of tachycardia per month and an electrophysiologic diagnosis of AVNRT were randomly assigned to catheter ablation or chronic antiarrhythmic drug (AAD) therapy with bisoprolol (5 mg od) and/or diltiazem (120-300 mg od). All patients were properly educated to treat subsequent tachycardia… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 22 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.
8 Citations
20 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy)

  • AS BMGoldberg, S Mickelsen, R Nawman, G West, FM. Kusumoto
  • Am J Cardiol 2002;89:1120–3
  • 2016

Similar Papers

Loading similar papers…